The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
A mum-of-three and breast cancer survivor is fighting for her life after being diagnosed with stage 3C ovarian cancer, less ...
During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...
Research shows that one in nine Indians may develop cancer at some point in their lives. Cancer is becoming a common disease, ...
Cancer remains a leading cause of death globally, with breast cancer being the most fatal for women. A recent American Cancer ...
14h
Inside Edition' reporter Alison Hall undergoes a double mastectomy, after discovering her breast cancer while on assignment.
The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast ...
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for ...
And, in fact, this study showed that the additional palbociclib to this kind of treatment was able to significantly prolong PFS from the start of the maintenance treatment with a benefit in terms of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback